皮肤分枝杆菌感染再思考：从流行病学到防治策略

doi:10.35541/cjd.20240467

Abstract

Abstract: 【Abstract】 Cutaneous mycobacterial infections are a kind of chronic infection caused by the genus Mycobacterium that usually affects the skin and soft tissues. The epidemiological features of cutaneous mycobacterial infections have undergone changes in recent years with the increase in global population mobility and environmental changes. This review aims to re-examine the epidemiology of, treatment strategies for, and preventive measures for cutaneous mycobacterial infections so as to enhance their diagnosis and treatment and to promote their prevention and control.

Key words: Mycobacterium infections, Skin, Epidemiology, Diagnosis, Prevention and treatment measures

Wang Hongsheng, Gan Tian. Rethinking cutaneous mycobacterial infections: from epidemiology to prevention and treatment strategies[J]. Chinese Journal of Dermatology, 2024, 57(11): 1011-1015.doi:10.35541/cjd.20240467

References ［58］

［1］	WHO. Global tuberculosis report 2023［EB/OL］. （2023⁃11⁃07）［2024⁃08⁃18］. https://www.who.int/publications/i/item/9789240083851.
［2］	WHO. Global tuberculosis report 2019［EB/OL］. （2019⁃10⁃15）［2024⁃08⁃18］. https://www.who.int/publications/i/item/9789241565714.
［3］	Li T, Yan X, Du X, et al. Extrapulmonary tuberculosis in China: a national survey［J］. Int J Infect Dis, 2023,128:69⁃77. doi: 10.1016/j.ijid.2022.12.005.
［4］	Mwiru RS, Nagu TJ, Kaduri P, et al. Prevalence and factors associated with alcohol drinking among HIV and tuberculosis co⁃infected patients in Dar es Salaam, Tanzania［J］. AIDS Care, 2018,30（2）:173⁃177. doi: 10.1080/09540121.2017.1344183.
［5］	Ankrah AO, Glaudemans A, Maes A, et al. Tuberculosis［J］. Semin Nucl Med, 2018,48（2）:108⁃130. doi: 10.1053/j.semnuclmed.2017.10.005.
［6］	Chen Q, Chen W, Hao F. Cutaneous tuberculosis: a great imitator［J］. Clin Dermatol, 2019,37（3）:192⁃199. doi: 10.1016/j.clindermatol.2019.01.008.
［7］	Maymone M, Laughter M, Venkatesh S, et al. Leprosy: clinical aspects and diagnostic techniques［J］. J Am Acad Dermatol, 2020,83（1）:1⁃14. doi: 10.1016/j.jaad.2019.12.080.
［8］	World Health Organization. World Health Organization. Global leprosy （hansen disease） update, 2019: time to step⁃up prevention initiatives［J］. Wkly Epidemiol Rec, 2020,95（36）:417⁃440.
［9］	World Health Organization. Global leprosy （hansen disease） update, 2022: new paradigm⁃control to elimination［J］. Wkly Epidemiol Rec, 2023, 98（37）: 409⁃430.
［10］	Shi Y, Sun PW, Wang L, et al. Epidemiology of leprosy in China, 2021: an update: ［J］. Int J Dermatol Venereol, 2024,7（1）:35⁃39. doi: 10.1097/JD9.0000000000000344.
［11］	Matsumoto Y, Kinjo T, Motooka D, et al. Comprehensive subspecies identification of 175 nontuberculous mycobacteria species based on 7547 genomic profiles［J］. Emerg Microbes Infect, 2019,8（1）:1043⁃1053. doi: 10.1080/22221751.2019.163 7702.
［12］	Fujishima C, Tahara J, Munemoto S, et al. Cutaneous nontuberculous mycobacterial infections in Japan: review of the Japanese literature［J］. J Dermatol, 2022,49（11）:1075⁃1084. doi: 10.1111/1346⁃8138.16531.
［13］	Sander MA, Isaac⁃Renton JL, Tyrrell GJ. Cutaneous nontuberculous mycobacterial infections in Alberta, Canada: an epidemiologic study and review［J］. J Cutan Med Surg, 2018,22（5）:479⁃483. doi: 10.1177/1203475418776945.
［14］	Mei Y, Zhang W, Shi Y, et al. Cutaneous tuberculosis and nontuberculous mycobacterial infections at a national specialized hospital in China［J］. Acta Derm Venereol, 2019,99（11）:997⁃1003. doi: 10.2340/00015555⁃3283.
［15］	Johansen MD, Herrmann JL, Kremer L. Non⁃tuberculous mycobacteria and the rise of Mycobacterium abscessus［J］. Nat Rev Microbiol, 2020,18（7）:392⁃407. doi: 10.1038/s41579⁃020⁃0331⁃1.
［16］	Wentworth AB, Drage LA, Wengenack NL, et al. Increased incidence of cutaneous nontuberculous mycobacterial infection, 1980 to 2009: a population⁃based study［J］. Mayo Clin Proc, 2013,88（1）:38⁃45. doi: 10.1016/j.mayocp.2012.06.029.
［17］	Chirasuthat P, Triyangkulsri K, Rutnin S, et al. Cutaneous nontuberculous mycobacterial infection in Thailand: a 7⁃year retrospective review［J］. Medicine （Baltimore）, 2020,99（10）:e19355. doi: 10.1097/MD.0000000000019355.
［18］	Franco⁃Paredes C, Marcos LA, Henao⁃Martínez AF, et al. Cutaneous mycobacterial infections［J］. Clin Microbiol Rev, 2018,32（1）:e00069⁃00018. doi: 10.1128/CMR.00069⁃18.
［19］	Henkle E, Winthrop KL. Nontuberculous mycobacteria infections in immunosuppressed hosts［J］. Clin Chest Med, 2015,36（1）:91⁃99. doi: 10.1016/j.ccm.2014.11.002.
［20］	Bohlen J, Zhou Q, Philippot Q, et al. Human MCTS1⁃dependent translation of JAK2 is essential for IFN⁃γ immunity to mycobacteria［J］. Cell, 2023,186（23）:5114⁃5134.e27. doi: 10.1016/j.cell.2023.09.024.
［21］	Qiu Y, Fang G, Ye F, et al. Pathogen spectrum and immunotherapy in patients with anti⁃IFN⁃γ autoantibodies: a multicenter retrospective study and systematic review［J］. Front Immunol, 2022,13:1051673. doi: 10.3389/fimmu.2022.1051673.
［22］	Mufti AH, Toye BW, Mckendry RR, et al. Mycobacterium abscessus infection after use of tumor necrosis factor alpha inhibitor therapy: case report and review of infectious complications associated with tumor necrosis factor alpha inhibitor use［J］. Diagn Microbiol Infect Dis, 2005,53（3）:233⁃238. doi: 10.1016/j.diagmicrobio.2005.06.006.
［23］	Sauer ME, Salomão H, Ramos GB, et al. Genetics of leprosy: expected⁃and unexpected⁃developments and perspectives［J］. Clin Dermatol, 2016,34（1）:96⁃104. doi: 10.1016/j.clindermatol. 2015.10.005.
［24］	Muniyandi M, Singh M, Singh M, et al. Cost⁃effectiveness of incorporating Mycobacterium indicus pranii vaccine to multidrug therapy in newly diagnosed leprosy cases for better treatment outcomes & immunoprophylaxis in contacts as leprosy control measures for National Leprosy Eradication Programme in India［J］. Indian J Med Res, 2021,154（1）:121⁃131. doi: 10. 4103/ijmr.IJMR_661_20.
［25］	van Ingen J, Kuijper EJ. Drug susceptibility testing of nontuberculous mycobacteria［J］. Future Microbiol, 2014,9（9）:1095⁃1110. doi: 10.2217/fmb.14.60.
［26］	Gardini G, Gregori N, Matteelli A, et al. Mycobacterial skin infection［J］. Curr Opin Infect Dis, 2022,35（2）:79⁃87. doi: 10. 1097/QCO.0000000000000820.
［27］	Wallace JR, Mangas KM, Porter JL, et al. Mycobacterium ulcerans low infectious dose and mechanical transmission support insect bites and puncturing injuries in the spread of Buruli ulcer［J］. PLoS Negl Trop Dis, 2017,11（4）:e0005553. doi: 10.1371/journal.pntd.0005553.
［28］	Wang SH, Pancholi P. Mycobacterial skin and soft tissue infection［J］. Curr Infect Dis Rep, 2014,16（11）:438. doi: 10. 1007/s11908⁃014⁃0438⁃5.
［29］	Jiang H, Jin Y, Vissa V, et al. Molecular characteristics of Mycobacterium tuberculosis strains isolated from cutaneous tuberculosis patients in China［J］. Acta Derm Venereol, 2017,97（4）:472⁃477. doi: 10.2340/00015555⁃2577.
［30］	Mei YM, Zhang WY, Sun JY, et al. Genomic characteristics of Mycobacterium tuberculosis isolates of cutaneous tuberculosis［J］. Front Microbiol, 2023,14:1165916. doi: 10.3389/fmicb.2023. 1165916.
［31］	Allué⁃Guardia A, García JI, Torrelles JB. Evolution of drug⁃resistant Mycobacterium tuberculosis strains and their adaptation to the human lung environment［J］. Front Microbiol, 2021,12:612675. doi: 10.3389/fmicb.2021.612675.
［32］	Li X, Li G, Yang J, et al. Drug resistance （Dapsone, Rifampicin, Ofloxacin） and resistance⁃related gene mutation features in leprosy patients: a systematic review and meta⁃analysis［J］. Int J Mol Sci, 2022,23（20）:12443. doi: 10.3390/ijms232012443.
［33］	Rosa PS, D'Espindula H, Melo A, et al. Emergence and transmission of drug⁃/multidrug⁃resistant Mycobacterium leprae in a former leprosy colony in the Brazilian Amazon［J］. Clin Infect Dis, 2020,70（10）:2054⁃2061. doi: 10.1093/cid/ciz570.
［34］	Johansen MD, Herrmann JL, Kremer L. Non⁃tuberculous mycobacteria and the rise of Mycobacterium abscessus［J］. Nat Rev Microbiol, 2020,18（7）:392⁃407. doi: 10.1038/s41579⁃020⁃0331⁃1.
［35］	van Ingen J, Boeree MJ, van Soolingen D, et al. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria［J］. Drug Resist Updat, 2012,15（3）:149⁃161. doi: 10.1016/j.drup.2012.04.001.
［36］	Liu CF, Song YM, He WC, et al. Nontuberculous mycobacteria in China: incidence and antimicrobial resistance spectrum from a nationwide survey［J］. Infect Dis Poverty, 2021,10（1）:59. doi: 10.1186/s40249⁃021⁃00844⁃1.
［37］	Lin WH, Yao C, Mei L, et al. Screening, epidemic trends and drug sensitivity analysis of nontuberculous mycobacteria in a local area of China［J］. Am J Transl Res, 2024,16（7）:3298⁃3305. doi: 10.62347/MAJY5046.
［38］	Hunkins JJ, de⁃Moura VC, Eddy JJ, et al. In vitro susceptibility patterns for rapidly growing nontuberculous mycobacteria in the United States［J］. Diagn Microbiol Infect Dis, 2023,105（3）:115882. doi: 10.1016/j.diagmicrobio.2022.115882.
［39］	Calado Nogueira de Moura V, Nguyen MH, Hunkins JJ, et al. In vitro susceptibility patterns for slowly growing non⁃tuberculous mycobacteria in the USA from 2018 to 2022［J］. J Antimicrob Chemother, 2023,78（12）:2849⁃2858. doi: 10.1093/jac/dkad317.
［40］	Roy A, Eisenhut M, Harris RJ, et al. Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta⁃analysis［J］. BMJ, 2014,349:g4643. doi: 10.1136/bmj.g4643.
［41］	Zimmermann P, Finn A, Curtis N. Does BCG vaccination protect against nontuberculous mycobacterial infection? A systematic review and meta⁃analysis［J］. J Infect Dis, 2018,218（5）:679⁃687. doi: 10.1093/infdis/jiy207.
［42］	Lange C, Aaby P, Behr MA, et al. 100 years of Mycobacterium bovis bacille Calmette⁃Guérin［J］. Lancet Infect Dis, 2022,22（1）:e2⁃e12. doi: 10.1016/S1473⁃3099（21）00403⁃5.
［43］	World Health Organization. Leprosy/hansen disease: contact tracing and post⁃exposure prophylaxis: technical guidance［M/OL］. （2020⁃11⁃15）［2024⁃08⁃18］. https://www.who.int/publications/i/item/9789290228073.
［44］	Wang L, Wang H, Yan L, et al. Single⁃dose rifapentine in household contacts of patients with leprosy［J］. N Engl J Med, 2023,388（20）:1843⁃1852. doi: 10.1056/NEJMoa2205487.
［45］	中国“一带一路”皮肤病专病联盟分枝杆菌病研究联盟，中国麻风防治协会皮肤性病检验与诊断分会. 中国皮肤结核临床诊疗专家共识（2024版）［J］. 中华皮肤科杂志, 2024,57（5）:426⁃434. doi: 10.35541/cjd.20230354.
［46］	Kromer C, Fabri M, Schlapbach C, et al. Diagnosis of mycobacterial skin infections［J］. J Dtsch Dermatol Ges, 2019,17（9）:889⁃893. doi: 10.1111/ddg.13925.
［47］	中国“一带一路”皮肤病专病联盟分枝杆菌病研究联盟, 中国麻风防治协会皮肤性病检验与诊断分会. 中国皮肤非结核分枝杆菌病诊治专家共识（2024版）［J］. 中华皮肤科杂志, 2024,57（2）:109⁃118. doi: 10.35541/cjd.20230371.
［48］	黄海荣. 非结核分枝杆菌相关实验室检查及其结果解读［J］. 中华结核和呼吸杂志, 2020,43（11）:910⁃913. doi: 10.3760/cma.j.cn112147⁃20200316⁃00346.
［49］	Jiang H, Shi Y, Chokkakula S, et al. Utility of multi⁃target Nested PCR and ELISPOT assays for the detection of paucibacillary leprosy: a possible conclusion of clinical laboratory misdiagnosis［J］. Front Cell Infect Microbiol, 2022,12:814413. doi: 10.3389/fcimb.2022.814413.
［50］	Huang C, Huang Y, Wang Z, et al. Multiplex PCR⁃based next generation sequencing as a novel, targeted and accurate molecular approach for periprosthetic joint infection diagnosis［J］. Front Microbiol, 2023,14:1181348. doi: 10.3389/fmicb.2023. 1181348.
［51］	Tsuchida S, Umemura H, Nakayama T. Current status of matrix⁃assisted laser desorption/ionization⁃time⁃of⁃flight mass spectrometry （MALDI⁃TOF MS） in clinical diagnostic microbiology［J］. Molecules, 2020,25（20）:4775. doi: 10.3390/molecules25204775.
［52］	Wu X, Tan G, Yang J, et al. Prediction of Mycobacterium tuberculosis drug resistance by nucleotide MALDI⁃TOF⁃MS［J］. Int J Infect Dis, 2022,121:47⁃54. doi: 10.1016/j.ijid.2022.04.061.
［53］	Alcaide F, Amlerová J, Bou G, et al. How to: identify non⁃tuberculous Mycobacterium species using MALDI⁃TOF mass spectrometry［J］. Clin Microbiol Infect, 2018,24（6）:599⁃603. doi: 10.1016/j.cmi.2017.11.012.
［54］	Barker C, Alshaikh H, Elston D. Dermatology practice updates in mycobacterial disease［J］. Int J Dermatol, 2024,63（6）:714⁃725. doi: 10.1111/ijd.16969.
［55］	Alemu Belachew W, Naafs B. Position statement: LEPROSY: diagnosis, treatment and follow⁃up［J］. J Eur Acad Dermatol Venereol, 2019,33（7）:1205⁃1213. doi: 10.1111/jdv.15569.
［56］	Lamb RC, Dawn G. Cutaneous non⁃tuberculous mycobacterial infections［J］. Int J Dermatol, 2014,53（10）:1197⁃1204. doi: 10.1111/ijd.12528.
［57］	Zhang X, Liu W, Liu W, et al. Cutaneous infections caused by rapidly growing mycobacteria: case reports and review of clinical and laboratory aspects［J］. Acta Derm Venereol, 2015,95（8）:985⁃989. doi: 10.2340/00015555⁃2105.
［58］	Gao X, Ding C, Xie D, et al. Contezolid⁃containing regimen successfully treated multiple drug resistance Mycobacterium Abscessus complex infection of skin: a case report and literature review［J］. Infect Drug Resist, 2024,17:1243⁃1249. doi: 10.2147/IDR.S453541.

[1]	Zou Xianbiao, Chen Jinchun, Zeng Yue, Hao Yi. Application of ultrasonography in dermatology: progress and prospects [J]. Chinese Journal of Dermatology, 2024, 57(9): 785-790.
[2]	Zeng Yue, Shao Huihong, Lin Shiwen, Wen Rou, Zou Xianbiao. Application of a wearable teleconsultation device in diagnosis of common skin diseases [J]. Chinese Journal of Dermatology, 2024, 57(9): 797-800.
[3]	He Lan, Ma Ling, Jiang Qian, Chen Liuqing, Chen Hongying. Analysis of dermoscopic and reflectance confocal microscopic characteristics of 57 cases of extragenital lichen sclerosus [J]. Chinese Journal of Dermatology, 2024, 57(9): 791-796.
[4]	Combination of Traditional and Western Medicine Dermatology, Chinese Society of Dermatology, China Dermatologist Association. Expert consensus on the application of reflectance confocal microscopy in common melanocytic skin tumors（2024） [J]. Chinese Journal of Dermatology, 2024, 57(9): 775-784.
[5]	Ye Jiaqi, Chai Weimin, Zheng Jie, Cao Hua. Evaluation of dermatomyositis complicated by interstitial lung disease based on skin lesions, serum biomarkers and radiological features [J]. Chinese Journal of Dermatology, 2024, 57(9): 863-866.
[6]	Lu Qing, Liu Yanqiu, Liu Danping, Zou Yongyi, Yang Bicheng. Variation analysis and prenatal diagnosis in a pedigree with oculocutaneous albinism [J]. Chinese Journal of Dermatology, 2024, 57(9): 842-843.
[7]	Hao Feng, Liu Guoyan. Application of optical coherence tomography in dermatology [J]. Chinese Journal of Dermatology, 2024, 57(9): 853-857.
[8]	Wang Ruixia, Qu Yanlei, Ai Wenjin, Yan Lin, Qu Caijie, Shi Tongxin. A case of nonbullous neutrophilic lupus erythematosus [J]. Chinese Journal of Dermatology, 2024, 57(9): 832-834.
[9]	Zhang Jiaqi, Wu Fan, Han Yuqing, Liu Qi, Pan Yao. Application of multi-photon microscopy in dermatology [J]. Chinese Journal of Dermatology, 2024, 57(9): 857-862.
[10]	Lin Ziyuan, Pang Tianyi, Wu Jingwen, Jin Hui, . Role of polycyclic aromatic hydrocarbons in the occurrence and development of inflammatory skin diseases [J]. Chinese Journal of Dermatology, 2024, 57(8): 765-769.
[11]	Xie yuanyuan, Liu Yuzhen, Zeng Rong, . Application of skin imaging techniques in acne vulgaris [J]. Chinese Journal of Dermatology, 2024, 57(8): 757-760.
[12]	Liu Qingfeng, Liu Lian, Diao Ping, Li Xiaoxue, Zhang Ting, Chen Haotian, Liu Xu, Jiang Xian. Diagnosis and treatment of port-wine stains-associated syndromes [J]. Chinese Journal of Dermatology, 2024, 57(7): 656-660.
[13]	Gao Ying, Wang Jiancai, Zhu Yun, Zhang Jianzhao, Yi Xiaoli, Bai Jinli, Qu Yujin. Clinical characteristics of and NF1 gene mutation analysis in 22 patients with neurofibromatosis type 1 [J]. Chinese Journal of Dermatology, 2024, 57(7): 637-644.
[14]	Jing Ke, Li Suo, Feng Suying. Clinical and immunoserological characteristics of 26 cases of linear IgA bullous dermatosis: a retrospective analysis [J]. Chinese Journal of Dermatology, 2024, 57(6): 503-509.
[15]	Han Yan, Xu Peng, Xiang Zhi, Jiang Tingting, Ge Fengqin, Yin Yueping, Chen Xiangsheng, . Strengthening research on prevention and treatment of chronic skin diseases — population medicine research program [J]. Chinese Journal of Dermatology, 2024, 57(6): 567-569.

Rethinking cutaneous mycobacterial infections: from epidemiology to prevention and treatment strategies

PDF

Knowledge

Abstract

Cite this article

share this article

References ［58］

Related Articles 15

Metrics

Comments

Recommended 10